Bank of Montreal’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-147,000
| Closed | -$2.74M | – | 3483 |
|
2022
Q4 | $2.74M | Hold |
147,000
| – | – | ﹤0.01% | 1388 |
|
2022
Q3 | $3.12K | Buy |
+147,000
| New | +$3.12K | ﹤0.01% | 1343 |
|
2021
Q2 | – | Sell |
-731
| Closed | -$13K | – | 3734 |
|
2021
Q1 | $13K | Sell |
731
-3,429
| -82% | -$61K | ﹤0.01% | 3827 |
|
2020
Q4 | $60K | Buy |
4,160
+2,907
| +232% | +$41.9K | ﹤0.01% | 3392 |
|
2020
Q3 | $20K | Sell |
1,253
-903
| -42% | -$14.4K | ﹤0.01% | 3428 |
|
2020
Q2 | $34K | Buy |
+2,156
| New | +$34K | ﹤0.01% | 3239 |
|
2020
Q1 | – | Sell |
-1,402
| Closed | -$35K | – | 3827 |
|
2019
Q4 | $35K | Buy |
1,402
+435
| +45% | +$10.9K | ﹤0.01% | 3486 |
|
2019
Q3 | $15K | Buy |
967
+41
| +4% | +$636 | ﹤0.01% | 3735 |
|
2019
Q2 | $23K | Buy |
926
+873
| +1,647% | +$21.7K | ﹤0.01% | 3622 |
|
2019
Q1 | $1K | Sell |
53
-44
| -45% | -$830 | ﹤0.01% | 3782 |
|
2018
Q4 | $3K | Buy |
97
+49
| +102% | +$1.52K | ﹤0.01% | 3868 |
|
2018
Q3 | $1K | Buy |
+48
| New | +$1K | ﹤0.01% | 4174 |
|